US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

108.98

+2.081.94%

Post-market: 108.89-0.0925-0.08%19:30 EDT

Volume:7K

Turnover:717.34K

Market Cap:119.88M

PE:- -

High:109.26

Open:108.98

Low:108.82

Close:106.91

52wk High:109.95

52wk Low:66.88

Shares:1.10M

Float Shares:1.10M

Volume Ratio:0.61

T/O Rate:0.60%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Anatara Lifesciences Narrows Annual Loss but Faces Going-Concern Warning

Coherus Oncology issuing special dividend of biosimilar contingent value rights

TYK Medicines Clarifies Board Structure and Committee Roles

Sandoz expands biosimilar pipeline with major Henlius collaboration

China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks

Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks

Press Release: AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Small-Molecule Generic Drug CRO Firm Sees Extreme Share Price Swings, Warns of No Innovation Drug Exposure

U.S. Stock Futures Flat as Traders Await Key Inflation Report

Australia’s biggest bank reports major drop in home loan applications‘There are clearly pockets of customer stress, given higher living costs and higher interest rates’.2 min read

Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development

AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit

Press Release: Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Alvotech to Report Financial Results for H1 2026

Bio-Gene Technology Seeks ASX Quotation for 15.2 Million New Shares

Grail announces FDA advisory committee meeting to review Galleri test PMA

U.K. Short-Dated Sovereign Bonds Look More Attractive than Eurozone Peers

Trump says rates should drop but it's not entirely up to Warsh

Ryan Chua / Bloomberg

ArborGen cancels CEO long-term incentive shares after departure

Biogen completes acquisition of RayThera

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BBP/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":108.9825,"timestamp":1787688000000,"preClose":106.906,"halted":0,"volume":6580,"hourTrading":{"tag":"盘后","latestPrice":108.89,"preClose":108.9825,"latestTime":"19:30 EDT","volume":9,"amount":981.3375,"timestamp":1787700600911,"change":-0.0925,"changeRate":-0.000849,"amplitude":0},"delay":0,"changeRate":0.01942360578452094,"floatShares":1100004,"shares":1100004,"eps":0,"marketStatus":"Not Yet Opened","change":2.0765,"latestTime":"08-25 16:00:00 EDT","open":108.98,"high":109.26,"low":108.82,"amount":717337.01872,"amplitude":0.004116,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":106.906,"sharesOutstanding":600004,"nav":106.659,"aum":117325193.93,"bidAskSpread":0.002308,"postHourTrading":{"tag":"盘后","latestPrice":108.89,"preClose":108.9825,"latestTime":"19:30 EDT","volume":9,"amount":981.3375,"timestamp":1787700600911,"change":-0.0925,"changeRate":-0.000849,"amplitude":0},"volumeRatio":0.614643,"impliedVol":0.2424,"impliedVolPercentile":0.6614},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1100004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.614643,"shares":1100004,"dividePrice":0,"high":109.26,"amplitude":0.004116,"preClose":106.906,"low":108.82,"week52Low":66.88,"pbRate":"--","week52High":109.945,"institutionHeld":0,"latestPrice":108.9825,"eps":0,"divideRate":0,"volume":6580,"delay":0,"ttmEps":0,"open":108.98,"prevYearClose":79.9149,"prevWeekClose":107.47,"prevMonthClose":93.8672,"prevQuarterClose":96.2686,"fiveDayClose":103.4785,"twentyDayClose":97.6934,"sixtyDayClose":86.5827},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660468019","title":"Anatara Lifesciences Narrows Annual Loss but Faces Going-Concern Warning","url":"https://stock-news.laohu8.com/highlight/detail?id=2660468019","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660468019?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:33","pubTimestamp":1787041986,"startTime":"0","endTime":"0","summary":"An announcement from Anatara Lifesciences Ltd ( ($AU:ANR) ) is now available. Anatara Lifesciences Ltd is a biotechnology company focused on develo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anatara-lifesciences-narrows-annual-loss-but-faces-going-concern-warning?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anatara-lifesciences-narrows-annual-loss-but-faces-going-concern-warning?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","JDOC","BBP","IBB","SYNB","XT","IEIH","FWD","RSPH","BK4585","DARP","AGNG","FHLC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660475437","title":"Coherus Oncology issuing special dividend of biosimilar contingent value rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2660475437","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660475437?lang=en_us&edition=fundamental","pubTime":"2026-08-18 05:40","pubTimestamp":1787002809,"startTime":"0","endTime":"0","summary":"Coherus Oncology (CHRS) announced a special dividend of contingent value rights which will be distributed on a pro rata basis to stockholders of re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/coherus-oncology-issuing-special-dividend-of-biosimilar-contingent-value-rights-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/coherus-oncology-issuing-special-dividend-of-biosimilar-contingent-value-rights-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VIG","ACKY","CHRS","BK4585","BK4139","BK4588","ACTV","BBP","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660448056","title":"TYK Medicines Clarifies Board Structure and Committee Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2660448056","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660448056?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:38","pubTimestamp":1786970320,"startTime":"0","endTime":"0","summary":"TYK Medicines, Inc. Class H ( ($HK:2410) ) just unveiled an update. TYK Medicines, Inc., a Hong Kong-listed pharmaceutical and biotechnology compan...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tyk-medicines-clarifies-board-structure-and-committee-roles?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tyk-medicines-clarifies-board-structure-and-committee-roles?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IBB","FWD","BBP","DARP","RSPH","XT","LNGR","FHLC","MDCO","SYNB","AGNG","JDOC","IEIH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660105197","title":"Sandoz expands biosimilar pipeline with major Henlius collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2660105197","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660105197?lang=en_us&edition=fundamental","pubTime":"2026-08-17 08:32","pubTimestamp":1786926779,"startTime":"0","endTime":"0","summary":"Sandoz Group Ltd ( ($CH:SDZ) ) has issued an announcement. Sandoz has signed a major development, manufacturing and commercialization deal with Sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sandoz-expands-biosimilar-pipeline-with-major-henlius-collaboration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sandoz-expands-biosimilar-pipeline-with-major-henlius-collaboration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EES","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108000527","title":"China Galaxy Securities: Laboratory Animals Are Essential for Innovative Drug R&D, High Demand for Mice and Monkeys on Two Main Tracks","url":"https://stock-news.laohu8.com/highlight/detail?id=1108000527","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108000527?lang=en_us&edition=fundamental","pubTime":"2026-08-14 15:38","pubTimestamp":1786693102,"startTime":"0","endTime":"0","summary":"China Galaxy Securities has released a research report stating that laboratory animals are a fundamental necessity for innovative drug research and development, with deep industry barriers. Two key...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSKH","161027","BK1564","BK4585","BK0276","BIOY","601881","BK0188","SBIO","BBP","BK1147","APXH","BK4588","06881","PBE","LFSC","XLVI","GDOC","WRND","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659926188","title":"Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659926188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659926188?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:37","pubTimestamp":1786567029,"startTime":"0","endTime":"0","summary":"The latest update is out from Outlook Therapeutics ( ($OTLK) ). On July 24, 2026, Outlook Therapeutics announced U.S. FDA approval of LYTENAVA (bev...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/outlook-therapeutics-ends-atm-prospectus-amid-ongoing-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/outlook-therapeutics-ends-atm-prospectus-amid-ongoing-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","GNMX","BK4139","IDNA","FRTY","TECB","NVIB","IBB","LENZ","IEIH","IYH","MRNX","XLVX","BMED","BK4007","RSPH","LFSC","MRNY","BK4585","LABU","SYNB","BBP","PSCH","TBXU","MEDI","PINK","BK4539","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659990095","title":"Press Release: AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659990095","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659990095?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:15","pubTimestamp":1786565700,"startTime":"0","endTime":"0","summary":"-- AEON held a successful Biosimilar Biological Product Development.  Type 2a meeting with the U.S. Food and Drug Administration.  during the first quarter of 2026. During the meeting, the. strategy under the 351 biosimilar pathway and provided feedback. ABP-450. Collectively, the FDA's feedback provided AEON with. well-defined direction and a framework for the remaining. analytical components of its biosimilar development program. The. associated with characterizing the 900 kDa botulinum neurotoxin. complex due to its large size and exceptional potency, while. analytical assessment plan. The Company looks forward to feedback. from its planned BPD Type 2b interaction with the FDA in the. second half of 2026, which is expected to help inform the next. phase of development for ABP-450, including clinical pharmacology. -- Strengthened Balance Sheet through a $15.3 Million Financing with","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4588","BK4585","BK4022","BK4139","AEON","LABU","BBP","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142463773","title":"Small-Molecule Generic Drug CRO Firm Sees Extreme Share Price Swings, Warns of No Innovation Drug Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=1142463773","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142463773?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:10","pubTimestamp":1786543834,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) issued a statement on August 12, revealing that its stock price has experienced an unusual surge, with cumulative closing price gains exceeding...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0102","SBIO","BK4585","XLVI","WRND","600721","LFSC","APXH","IBB","BBP","BIOY","BK0216","BK4588","GDOC","GSKH","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658949156","title":"U.S. Stock Futures Flat as Traders Await Key Inflation Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2658949156","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658949156?lang=en_us&edition=fundamental","pubTime":"2026-08-12 06:14","pubTimestamp":1786486471,"startTime":"0","endTime":"0","summary":"U.S. stock futures were steady on Tuesday evening as traders waited for a key inflation report that could guide the next move on interest rates. Fu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/u-s-stock-futures-flat-as-traders-await-key-inflation-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/u-s-stock-futures-flat-as-traders-await-key-inflation-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FLV","VOTE","SAMT","CGDV","EQRR","FXL","RMIF","DECU","CAOS","LGH","FXR","PEVC","BBP","EES","PRVS","CGUI","FT","MAPP","VAW","ADPV","MODL","BKDV","IUS","DFUV","FXD","IJK","IMCG","RULE","TSLP","CDC","VTV","BAMA","SDOG","ANEW","CLIX","ARP","DIVZ","ILCV","REGL","RHTX","UCC","MDLV","KOMP","LCG","CGUS","MATR","TEQI","AVSD","BSR","PSC","HIDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658928457","title":"Australia’s biggest bank reports major drop in home loan applications‘There are clearly pockets of customer stress, given higher living costs and higher interest rates’.2 min read","url":"https://stock-news.laohu8.com/highlight/detail?id=2658928457","media":"7NEWS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658928457?lang=en_us&edition=fundamental","pubTime":"2026-08-12 00:00","pubTimestamp":1786464000,"startTime":"0","endTime":"0","summary":"Be the first to know: Add 7NEWS as your preferred news source on GoogleCBA’s annual report highlights a focus on AI, with 80 per cent of its staff now using the technology each week. The bank has opened an office in Silicon Valley to partner with AI developers as its seeks to deliver better customer service at greater speed. “We think we’re going to get a lot more done, given the velocity benefits,” said Docherty.However, CBA noted AI was a double-edged sword and being weaponised by scammers, with the bank now spending a billion dollars a year to protect customers from increasingly sophisticated fraud. It’s sending 40,000 fraud alerts to customers each day.CommBank is the nation’s biggest financial institution, with one in three Australians naming it as their primary bank. It now boasts 18.6-million customers, with the largest branch network in the land. The bank says its popular app is now recording more than 14-million log-ins each day.Driver’s terrifying near-miss with iconic touris","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"7news_stock","url":"https://7news.com.au/news/commonwealth-bank-warns-economic-growth-is-slowing-reports-major-drop-in-home-loan-applications-c-22712205","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://7news.com.au/news/commonwealth-bank-warns-economic-growth-is-slowing-reports-major-drop-in-home-loan-applications-c-22712205","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"7news_stock","symbols":["UCC","TSLI","EIGA.AU","KOMP","QOWZ","VAW","OZF.AU","ZYAU.AU","FXR","TSDD","TSII","BBP","RJZ","RWVG","TSL","TSLP","AVSD","OZR.AU","DFND","IJK","XJO.AU","TSLG","IOZ.AU","TSLR","XAO.AU","DACE.AU","TSLQ","TSLS","CAOS","TSLY","E200.AU","LRCY","ELOL","PEVC","PEX","XKO.AU","VAS.AU","DFUV","QRE.AU","TSYY","TSLO","CRSH","CGDV","IISV.AU","BBOZ.AU","ANEW","CLIX","FXL","BEAR.AU","IMLC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174341976","title":"Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1174341976","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174341976?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:08","pubTimestamp":1786450094,"startTime":"0","endTime":"0","summary":"Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd. (600721.SH) has issued a stock trading risk warning announcement, stating that it is a CRO enterprise primarily focused on the research and development of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOY","SBIO","GDOC","APXH","XLVI","LFSC","BK0216","BK4588","600721","GSKH","WRND","BK4585","PBE","IBB","BK0102","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118729610","title":"AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=1118729610","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118729610?lang=en_us&edition=fundamental","pubTime":"2026-08-11 14:12","pubTimestamp":1786428745,"startTime":"0","endTime":"0","summary":"A research report from Orient Securities Company Limited highlights that as global regulatory shifts accelerate, the large-scale application of AI in pharmaceuticals is rapidly advancing. It has...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0276","LFSC","BIOY","WRND","AIPO","VTHR","BK1147","BK0188","PBE","AGIX","XLVI","CHAT","QTOC","03958","BK0183","BK1564","BK0028","600958","BK0012","SBIO","BBP","BK4585","BK4588","APXH","GSKH","IBB","GDOC","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658993909","title":"Press Release: Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=2658993909","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658993909?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:01","pubTimestamp":1786366860,"startTime":"0","endTime":"0","summary":"Seasoned biotechnology founder, public company CFO and corporate strategist brings more than 25 years of leadership in oncology, capital markets, M&A and corporate governanceAppointment further streng","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","BK4581","BK4007","ERNA","IND","BK4205","RFL","IBB","BK4539","BK4585","SYNB","BBP","BK4233","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658293667","title":"Alvotech to Report Financial Results for H1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2658293667","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658293667?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:00","pubTimestamp":1786363200,"startTime":"0","endTime":"0","summary":"REYKJAVIK, Iceland, Aug.  10, 2026  (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/10/3341796/0/en/alvotech-to-report-financial-results-for-h1-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BBP","ALVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658960430","title":"Bio-Gene Technology Seeks ASX Quotation for 15.2 Million New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2658960430","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658960430?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:17","pubTimestamp":1786331840,"startTime":"0","endTime":"0","summary":"Bio-Gene Technology Ltd. ( ($AU:BGT) ) just unveiled an announcement. Bio-Gene Technology Ltd., an ASX-listed biotechnology company trading under t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bio-gene-technology-seeks-asx-quotation-for-15-2-million-new-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bio-gene-technology-seeks-asx-quotation-for-15-2-million-new-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","IEIH","IBB","RSPH","BGT","BK4585","FHLC","AGNG","BK4588","LNGR","XT","JDOC","SYNB","BBP","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642727","title":"Grail announces FDA advisory committee meeting to review Galleri test PMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642727","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642727?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:10","pubTimestamp":1786115445,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBT","LABU","XBIX","BK4585","BK4139","IBRN","SBIO","BBH","BBP","GRAL","BK4588","BK4129","PBE","PMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657428836","title":"U.K. Short-Dated Sovereign Bonds Look More Attractive than Eurozone Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657428836","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657428836?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:36","pubTimestamp":1786113360,"startTime":"0","endTime":"0","summary":"1436 GMT - U.K. short-term government bonds could outperform their eurozone counterparts, Bank of America strategists say in a note. The Bank of England looks less likely to increase interest rates in the near term given U.K.'s weak economic data, while the European Central Bank has a higher possibility of raising interest rates, the strategists say.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TACN","AVSD","EPV","ANEW","CLIX","VAW","FXL","FXR","DFUV","KOMP","BAC","ISVL","RJZ","UCC","TSLP","LRCY","IJK","CAOS","BBEU","BBP","PEVC","CGDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657243666","title":"Trump says rates should drop but it's not entirely up to Warsh","url":"https://stock-news.laohu8.com/highlight/detail?id=2657243666","media":"Ryan Chua / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657243666?lang=en_us&edition=fundamental","pubTime":"2026-08-07 11:53","pubTimestamp":1786074815,"startTime":"0","endTime":"0","summary":"President Donald Trump repeated his preference for lower interest rates but said it is not the Fed chief's decision alone, taking a much softer tone than the sharp criticisms he levelled at Powell.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/us-economy/trump-says-rates-should-drop-its-not-entirely-warsh?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/us-economy/trump-says-rates-should-drop-its-not-entirely-warsh?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["TEST","09366","TSLI","CRSH","TSLS","CGDV","LRCY","TSLY","UCC","TSLQ","TSLT","VAW","TSLP","TSLZ","TSLO","07366","FXL","CAOS","CLIX","BK4585","IJK","BK4588","PEVC","TSLR","TSL","FXR","BBP","TESL","DFUV","ANEW","TSLW","09766","07766","AVSD","TSYY","TLA","KOMP","TSII","TSLG","TSLL","TSDD","RJZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657867667","title":"ArborGen cancels CEO long-term incentive shares after departure","url":"https://stock-news.laohu8.com/highlight/detail?id=2657867667","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657867667?lang=en_us&edition=fundamental","pubTime":"2026-08-07 08:49","pubTimestamp":1786063753,"startTime":"0","endTime":"0","summary":"ArborGen Holdings ( ($NZ:ARB) ) has issued an update. ArborGen Holdings Limited, a forestry and agricultural biotechnology company, provides geneti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arborgen-cancels-ceo-long-term-incentive-shares-after-departure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arborgen-cancels-ceo-long-term-incentive-shares-after-departure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4582","IVEG","JDOC","BBP","FWD","IEIH","AGNG","LNGR","BK4585","BK4588","RSPH","SYNB","WOOD","DARP","XT","ARB","FHLC","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657050661","title":"Biogen completes acquisition of RayThera","url":"https://stock-news.laohu8.com/highlight/detail?id=2657050661","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657050661?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:55","pubTimestamp":1786056934,"startTime":"0","endTime":"0","summary":"Biogen (BIIB) announced the completion of the acquisition of RayThera Inc., a privately held biotechnology company focused on discovering and devel...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biogen-completes-acquisition-of-raythera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biogen-completes-acquisition-of-raythera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","IE00B19Z9P08.USD","RSPH","BK4139","LNGR","PBE","IBB","JDOC","LU0889565916.HKD","LU0109394709.USD","FWD","BBP","IEIH","SYNB","IE00B894F039.SGD","BK4532","FHLC","AGNG","BIIB","BMED","LU0320765992.SGD","BK4585","IE00B19Z9Z06.USD","XT","BK4588","BK4533","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":114,"code":"91000000","status":"200"}]}}